Cargando…
CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women
SIMPLE SUMMARY: The elimination of drugs by enzymes in the liver may be impaired in cancer patients that are close to death (end-of-life). This could cause unwanted side effects or lack of effect of drugs and compromise the quality of life in patients. Blood samples collected in 137 deceased end-of-...
Autores principales: | Bergström, Helena, Helde Frankling, Maria, Klasson, Caritha, Lövgren Sandblom, Anita, Diczfalusy, Ulf, Björkhem-Bergman, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465465/ https://www.ncbi.nlm.nih.gov/pubmed/34572915 http://dx.doi.org/10.3390/cancers13184689 |
Ejemplares similares
-
Successful Strategies and Areas of Improvement–Lessons Learned from Design and Conduction of a Randomized Placebo-Controlled Trial in Palliative Care, ‘Palliative-D’
por: Helde Frankling, Maria, et al.
Publicado: (2021) -
25-Hydroxyvitamin D in Cancer Patients Admitted to Palliative Care: A Post-Hoc Analysis of the Swedish Trial ‘Palliative-D’
por: Helde Frankling, Maria, et al.
Publicado: (2022) -
Fatigue in Cancer Patients in Palliative Care—A Review on Pharmacological Interventions
por: Klasson, Caritha, et al.
Publicado: (2021) -
Appetite in Palliative Cancer Patients and Its Association with Albumin, CRP and Quality of Life in Men and Women—Cross-Sectional Data from the Palliative D-Study
por: Goodrose-Flores, Charlotte, et al.
Publicado: (2022) -
Differences in discontinuation of statin treatment in women and men with advanced cancer disease
por: Bergström, Helena, et al.
Publicado: (2018)